In this study, T2D patients expressed elevated levels of CDKN2A, and specifically of CDKN2A tv3 and 4: the first one highly associated with serum insulin levels in patients, and the second one with certain T2D-risk factors in controls. The gene discussed is INS; the disease is type 2 diabetes mellitus.